OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
Albert Liu, Xiao Wang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration
Mincheol Jang, Kyunghwan Yeom, Junhee Han, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24204-24218
Closed Access | Times Cited: 2

Bisulfite and Nanopore Sequencing for Pseudouridine in RNA
Cynthia J. Burrows, Aaron M. Fleming
Accounts of Chemical Research (2023) Vol. 56, Iss. 19, pp. 2740-2751
Open Access | Times Cited: 7

The regulation of antiviral innate immunity through non-m6A RNA modifications
Shenghai Shen, Lisheng Zhang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5

Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review
Smita C. Pawar, Prashant Pingale, Atul Garkal, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131139-131139
Closed Access | Times Cited: 1

Delivery of mRNA with Histidine-Lysine Peptides
Qixin Leng, Jiaxi He, Aishwarya Anand, et al.
Methods in molecular biology (2024), pp. 367-386
Closed Access | Times Cited: 1

The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 1

Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects
Urmila Kafle, H-H M Truong, Cường Quốc Nguyễn, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 12, pp. 5944-5959
Closed Access | Times Cited: 1

Non-viral delivery of RNA for therapeutic T cell engineering
Dominika Berdecka, Stefaan C. De Smedt, Winnok H. De Vos, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115215-115215
Open Access

Selective Arylation of RNA 2′‐OH Groups via SNAr Reaction with Trialkylammonium Heterocycles
Sayantan Chatterjee, Lu Xiao, Wenrui Zhong, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 25
Closed Access

Detection and Quantification of 5moU RNA Modification from Direct RNA Sequencing Data
Jiayi Li, Feiyang Sun, Kunyang He, et al.
Current Genomics (2024) Vol. 25, Iss. 3, pp. 212-225
Open Access

mRNA therapeutics in diseases: Light inspect into a new horizon
Yanhui Li
Theoretical and Natural Science (2024) Vol. 44, Iss. 1, pp. 111-122
Open Access

Innovations in mRNA-based cancer immunotherapy: Challenges and future directions
Matthew Essuah, Buniechukwuenu Emmanuel Mbamalu, Ridwan Ayodele Akanmu, et al.
World Journal of Biology Pharmacy and Health Sciences (2024) Vol. 20, Iss. 2, pp. 702-724
Open Access

Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity
Mahboubeh Hosseini-Kharat, Kristen E. Bremmell, Branka Grubor‐Bauk, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 170-194
Open Access

Position-Specific Nucleoside Sugar Modifications in mRNA ORF: Enhancing Translational Function through Complete Chemical Synthesis of mRNA
Hiroshi Abe, Yasuaki Kimura, Masakazu Honma, et al.
Research Square (Research Square) (2024)
Closed Access

RNA Structure: Past, Future, and Gene Therapy Applications
William A. Haseltine, Kim Hazel, Roberto Patarca
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 110-110
Open Access

Development of Non-Viral Targeted RNA Delivery Vehicles – A Key Factor in Success of Therapeutic RNA
Muhammad Waqas Choudry, Rabia Riaz, Muhammad Hassan Raza, et al.
Journal of drug targeting (2024), pp. 1-14
Closed Access

mRNA Vaccine Sequence and Structure Design and Optimization: Advances and Challenges
Lei Jin, Yuanzhe Zhou, Sicheng Zhang, et al.
Journal of Biological Chemistry (2024), pp. 108015-108015
Open Access

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 569-569
Open Access | Times Cited: 1

Towards the controlled enzymatic synthesis of LNA containing oligonucleotides
Nazarii Sabat, Dace Katkevica, Kārlis Pajuste, et al.
(2023)
Open Access | Times Cited: 1

Detection and quantification of 5moU RNA modification from direct RNA sequencing data
Jiayi Li, Feiyang Sun, Kunyang He, et al.
Research Square (Research Square) (2023)
Open Access

Predicting nearest neighbor free energies of modified RNA with LIE: results for pseudouridine and N1-methylpseudouridine within RNA duplexes
Nivedita Dutta, Joanna Sarzyńska, Indrajit Deb, et al.
Physical Chemistry Chemical Physics (2023) Vol. 26, Iss. 2, pp. 992-999
Closed Access

Scroll to top